Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Short Interest Up 418.6% in May

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) saw a large increase in short interest in the month of May. As of May 15th, there was short interest totaling 413,714 shares, an increase of 418.6% from the April 30th total of 79,768 shares. Based on an average trading volume of 1,160,884 shares, the short-interest ratio is currently 0.4 days. Currently, 0.0% of the shares of the stock are short sold.

Coloplast A/S Price Performance

CLPBY stock opened at $6.20 on Friday. The company has a 50 day simple moving average of $6.53 and a 200 day simple moving average of $7.72. The stock has a market cap of $13.97 billion, a price-to-earnings ratio of 44.29, a P/E/G ratio of 1.97 and a beta of 0.15. Coloplast A/S has a 1 year low of $6.10 and a 1 year high of $10.03. The company has a debt-to-equity ratio of 1.50, a current ratio of 1.30 and a quick ratio of 0.81.

Coloplast A/S (OTCMKTS:CLPBY) last released its quarterly earnings data on Tuesday, May 12th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. Coloplast A/S had a net margin of 7.46% and a return on equity of 31.96%. The business had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.11 billion. Research analysts anticipate that Coloplast A/S will post 0.4 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. The Goldman Sachs Group downgraded shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a report on Tuesday, April 7th. Kepler Capital Markets upgraded shares of Coloplast A/S to a “strong-buy” rating in a research report on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold”.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.